1 / 8

Developing the Appropriate Monitoring Program for Regultory Decision Making (Human Health 2)

Developing the Appropriate Monitoring Program for Regultory Decision Making (Human Health 2). Outcomes and goals – Where do we want to end up? What we are NOT looking for: No magic list, any program will be hypothesis driven in design and dependant upon site specific issues.

shubha
Download Presentation

Developing the Appropriate Monitoring Program for Regultory Decision Making (Human Health 2)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Developing the Appropriate Monitoring Program for Regultory Decision Making(Human Health 2)

  2. Outcomes and goals – Where do we want to end up? • What we are NOT looking for: No magic list, any program will be hypothesis driven in design and dependant upon site specific issues. • Monitoring can identify areas of risk, but also can test performance. • Pharmaceticals, DBPs, Industrial chems, etc may be good surrogates for treatment plant performance.

  3. Questions for Design of Program • How low to measure – should be risk based. • DO NOT CHASE ZERO!!! • What do you monitor? • For human health, for some chemicals highest exposure would be in the home. • Treatment performance and needs of regulators. • Risk communication is critical: Need to do a good job of communicating purpose to general public • How frequent? • More at start-up • Less with time

  4. General Issues • Transformation compounds – what does the treatment process convert the chemical to. • Any system/program must include expert judgment. • Improve Research Agenda • “uncertainty is the driver” – trying to answer questions we don’t know the answer to. • To provide information for improved policy decisions

  5. Regulator’s paradigm: • Programmatic pollutants • Contaminant-by-contaminant regulation is of limited use. • Goal is to move to treatment technology approach (improve treatment). • Program specific monitoring programs • Chemicals from urban runoff and agricultural sources will be different

  6. Questions: • What are appropriate parameters for CECs? • List of analytes needs to be revised/revisited every so often. • Use patterns change, new applications for wastewater/biosolids • Where is the greatest probability for detecting a problem for human health exposure: at the tap. • Transparency and Risk communication is huge. All information is public.

  7. Criteria used to select candidate analytical methods. • Thresholds should be risk-based for compliance monitoring. Avoid chasing zero. • Standard methods should be used where possible, however need a state organization to facilitate needs for development of performance based standards for non-standard methods. • Need money for lab methods.

  8. Non traditional techniques and ecological/human health endpoints • State has a biomonitoring (CECDP) program • If something new is found, need mechanism to get this info to facilitate method development for water monitoring. • Possibly liason to meet with Blue Ribbon Panel.

More Related